Suppr超能文献

2010 年更新的 ASAS/EULAR 强直性脊柱炎治疗建议。

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

机构信息

Rheumazentrum Ruhrgebiet, Landgrafenstrasse 15, 44652 Herne, Germany.

出版信息

Ann Rheum Dis. 2011 Jun;70(6):896-904. doi: 10.1136/ard.2011.151027.

Abstract

This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature since 2005 and the discussion and agreement among 21 international experts, 2 patients and 2 physiotherapists in a meeting in February 2010. Each original bullet point was discussed in detail and reworded if necessary. Decisions on new recommendations were made - if necessary after voting. The strength of the recommendations (SOR) was scored on an 11-point numerical rating scale after the meeting by email. These recommendations apply to patients of all ages that fulfill the modified NY criteria for AS, independent of extra-articular manifestations, and they take into account all drug and non-drug interventions related to AS. Four overarching principles were introduced, implying that one bullet has been moved to this section. There are now 11 bullet points including 2 new ones, one related to extra-articular manifestations and one to changes in the disease course. With a mean score of 9.1 (range 8-10) the SOR was generally very good.

摘要

这是 ASAS/EULAR 关于强直性脊柱炎(AS)管理的建议的首次更新,基于原始论文、对 2005 年以来现有建议和文献的系统评价,以及 21 名国际专家、2 名患者和 2 名物理治疗师在 2010 年 2 月会议上的讨论和达成的共识。每个原始要点都进行了详细讨论,并在必要时进行了改写。对于新建议,在必要时进行了投票。会后通过电子邮件对建议的强度(SOR)进行了 11 分制的评分。这些建议适用于符合改良纽约标准的所有年龄段的 AS 患者,无论是否有关节外表现,并且考虑到与 AS 相关的所有药物和非药物干预措施。引入了四项总体原则,这意味着有一个要点已被移至本节。现在共有 11 个要点,包括 2 个新要点,一个与关节外表现有关,一个与疾病进程变化有关。SOR 的平均得分为 9.1(范围 8-10),总体非常好。

相似文献

1
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.
Ann Rheum Dis. 2011 Jun;70(6):896-904. doi: 10.1136/ard.2011.151027.
4
ASAS/EULAR recommendations for the management of ankylosing spondylitis.
Ann Rheum Dis. 2006 Apr;65(4):442-52. doi: 10.1136/ard.2005.041137. Epub 2005 Aug 26.
5
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ann Rheum Dis. 2023 Jan;82(1):19-34. doi: 10.1136/ard-2022-223296. Epub 2022 Oct 21.
9
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.
Ann Rheum Dis. 2006 Dec;65(12):1620-5. doi: 10.1136/ard.2005.042630. Epub 2006 Feb 7.

引用本文的文献

3
Morphological examination of the normal kidney and urinary bladder in goats () using anatomical sections and computed tomography.
Open Vet J. 2025 Feb;15(2):820-826. doi: 10.5455/OVJ.2025.v15.i2.31. Epub 2025 Feb 28.
6
Five Cases of Non-radiographic Spondyloarthritis (nr-SpA) of Patients from a Tertiary Care Center in the Philippines: A Case Series.
Acta Med Philipp. 2024 Nov 29;58(21):106-110. doi: 10.47895/amp.vi0.8251. eCollection 2024.
7
Rationale and concerns for using JAK inhibitors in axial spondyloarthritis.
Rheumatol Adv Pract. 2024 Nov 7;8(4):rkae141. doi: 10.1093/rap/rkae141. eCollection 2024.
8
Value of the central sensitisation inventory in patients with axial spondyloarthritis.
RMD Open. 2024 Oct 28;10(4):e004528. doi: 10.1136/rmdopen-2024-004528.
10
Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report.
World J Clin Cases. 2024 Aug 16;12(23):5441-5447. doi: 10.12998/wjcc.v12.i23.5441.

本文引用的文献

2
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study.
Ann Rheum Dis. 2011 Jun;70(6):1108-10. doi: 10.1136/ard.2010.145946. Epub 2011 Mar 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验